Capital Bank & Trust’s Elevance Health ELV Stock Holding History

Capital Bank & Trust’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-149,680	Closed	-$57.1M	–	68
2021 Q2	$57.1M	Sell	149,680 -570	-0.4%	-$218K	0.66%	53
2021 Q1	$53.9M	Buy	150,250 +1,655	+1%	+$532K	0.64%	50
2020 Q4	$47.7M	Sell	148,595 -664	-0.4%	-$204K	0.58%	51
2020 Q3	$40.1M	Sell	149,259 -73,069	-33%	-$19.7M	0.54%	56
2020 Q2	$58.5M	Buy	222,328 +10,455	+5%	+$2.79M	0.85%	43
2020 Q1	$48.1M	Buy	211,873 +53,658	+34%	+$14.6M	0.81%	44
2019 Q4	$47.8M	Buy	158,215 +104,097	+192%	+$28.6M	0.62%	54
2019 Q3	$13M	Buy	54,118 +2,881	+6%	+$789K	0.18%	103
2019 Q2	$14.5M	Buy	51,237 +50,688	+9,233%	+$13.8M	0.18%	105
2019 Q1	$158K	Hold	549	–	–	﹤0.01%	297
2018 Q4	$144K	Hold	549	–	–	﹤0.01%	319
2018 Q3	$150K	Hold	549	–	–	﹤0.01%	314
2018 Q2	$131K	Hold	549	–	–	﹤0.01%	317
2018 Q1	$121K	Hold	549	–	–	﹤0.01%	312
2017 Q4	$124K	Buy	549 +51	+10%	+$10.9K	﹤0.01%	331
2017 Q3	$95K	Hold	498	–	–	﹤0.01%	330
2017 Q2	$94K	Buy	+498	New	+$89.5K	﹤0.01%	313

Other funds holding ELV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

Capital Bank & Trust's ELV Position: Q3 2021 in Review

Capital Bank & Trust sold out of Elevance Health (ELV) in Q3 2021, closing a stake of 149,680 shares — an estimated $57.1M sold.

Capital Bank & Trust first reported a position in ELV in Q2 2017 and held it in 17 quarters. The position peaked at $58.5M in Q2 2020. 1,214 funds tracked by Wall St. Rank hold ELV as of Q3 2021.

Capital Bank & Trust reported no remaining Elevance Health position as of Q3 2021 after selling out during the quarter.
Capital Bank & Trust sold 149,680 Elevance Health shares in Q3 2021, an estimated $57.1M.
Capital Bank & Trust first reported a position in Elevance Health in Q2 2017 and held it in 17 quarters.
Capital Bank & Trust's Elevance Health position peaked at $58.5M in Q2 2020.
1,214 funds tracked by Wall St. Rank held Elevance Health as of Q3 2021.

Based on Capital Bank & Trust's 13F filing for Q3 2021, filed 15 Nov 2021.